"We could be right at the start of this process, right now," a popular X user claimed.
GSK to advance its mRNA flu vaccine into phase III after phase II study has shown stronger immune responses and good tolerability.
For investors seeking momentum, Alpha Architect 1-3 Month Box ETF BOXX is probably on the radar. The fund just hit a 52-week high and has risen 4.06% from its 52-week low price of $113.50/share.
THORChain's transparency initiative could set a new standard for accountability in DeFi, potentially boosting user trust and adoption. THORChain launches public dashboard tracking revenue and trading metrics.
We saw a bit of recovery in the stock market since the US open, with the dollar easing lower on suspected BoJ intervention in the USD/JPY helping to calm the nerves. That in turn helped to provide some support for gold, too.
TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study Transcript
Bitcoin and XRP are reviving an old crypto market meme as their recent price action begins to resemble the famous Bart Simpson chart pattern, raising concerns about a potentially sharper cryptocurrency market correction. The formation, named after the spiky-haired character from The Simpsons, describes a rapid price surge followed by sideways trading and an abrupt reversal.
French cryptocurrency treasury firm Capital B (ALCPB) has raised 7.6 million ($8.8 million) from prominent Bitcoin developer and investor Adam Back as it seeks to significantly expand its Bitcoin holdings. The Euronext Growth Paris-listed company issued 13,181,030 new shares to Back at 0.58 per share, with each share accompanied by four warrants, according to a Wednesday filing.
Visitors to Costco Next have been met with confusion and consternation over the past several days after the wholesale giant's curated marketplace for select third-party goods appears to have abruptly shut down without notice. Here's what you need to know.
CRDO's strong Q1 growth and AI demand face a key test as optical ramps, customer concentration and valuation raise risks.
Applied Materials' AI exposure, broad portfolio and capacity expansion fuel growth, but its premium valuation raises the stakes.
Hershey's pricing drives organic sales growth, but steep volume declines and elasticity remain key tests as the company enters the second half.
Pace is weak now, but the October tokenisation launch could help network the back to its feet.
GitLab TodayGTLBGitLab$50.88 +5.79 (+12.84%) As of 12:09 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$18.73▼$55.55Price Target$51.88Add to WatchlistGitLab's NASDAQ: GTLB SaaS-pocalypse rebound is gaining momentum after a software-validating earnings report.
Centrifuge, Janus Henderson, and SMT launch tokenized onchain vaults to manage loyalty program reserves, targeting a $300 billion annual Centrifuge integrates onchain reserve management for loyalty programs with Janus Henderson and SMT.
Solana's accelerated disinflation could enhance token scarcity, potentially boosting value, but may impact validator incentives and network dynamics. Solana approves change to token issuance schedule with 67% support.
Celestica estimates are rising as AI infrastructure demand, new hyperscaler programs and strong cash flow boost Celestica's growth outlook.
Bitcoin and the broader cryptocurrency market are facing renewed selling pressure as rising oil prices, a stronger U.S. dollar and expectations for higher interest rates weigh on risk assets. Bitcoin (BTC) traded around $77,277 as crypto markets followed recent weakness in U.S. equities.
ArbitrumDAO's robust income and strategic expansion enhance its financial autonomy, positioning it for sustained growth and influence in the blockchain ecosystem. ArbitrumDAO reports $6M income in first half of 2026.
Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.
Strategy has resumed its Bitcoin accumulation after a roughly two-month pause, purchasing 4,603 BTC for about $369.7 million.
FuelCell Energy NASDAQ: FCEL reported third-quarter fiscal 2026 revenue of $33 million, down 29% from $46.7 million in the prior-year period, as fewer module deliveries to South Korea and lower generation output weighed on results. The company also highlighted new data-center-related commercial activity, including a 30-megawatt initial order under an agreement with Fit Energy and a subsequent 75-megawatt capacity reservation with a major colocation data center operator for a Texas project.
Brown Forman NYSE: BF.A said its first-quarter fiscal 2027 results were largely in line with expectations, as growth from ready-to-drink products and Jack Daniel's Tennessee Blackberry helped offset pressure in used barrel sales, tequila and several developed international markets.
REX American Resources NYSE: REX reported record second-quarter earnings per share for fiscal 2026, supported by stronger ethanol margins, improved product pricing and contributions from the Section 45Z production tax credit program.
Kraft Heinz bets on bigger, consumer-led innovations to revive volumes, with new launches showing early traction, but companywide volume/mix is still down 2.6%.
SYY targets 6-7% fiscal 2027 sales growth and 9-11% adjusted earnings growth, but costs, traffic and Restaurant Depot uncertainty keep risks in focus.
T gains 4.7% YTD as fiber and wireless growth support momentum, while heavy investment, competition and debt remain key challenges.
As Space Exploration Technologies Corp. (NASDAQ: SPCX) stock remained above its IPO (Initial Public Offering) price over the past four weeks through September 2, 2026, Timothy Horan, a Wall Street analyst at Oppenheimer, is more convinced that SpaceX could rally to a new all-time high (ATH) over the next 12 months.
Hyperliquid's ecosystem growth and HYPE's breakout could set the stage for stronger accumulation in Q4.
Two CNBC voices looked at the same stock inside the same 12-hour window and reached opposite conclusions about what it needs.